Paxlovid Has Been Free So Far. Next Year, Sticker Shock Awaits.
The government soon will stop paying for the covid drug that has proved to be the most effective at keeping patients alive and out of the hospital.
The independent source for health policy research, polling, and news.
861-880 of 1,205 results
The government soon will stop paying for the covid drug that has proved to be the most effective at keeping patients alive and out of the hospital.
The Florida policy backed by Gov. Ron DeSantis relies on one key statistic that many experts question.
Like many U.S. workplaces, the Centers for Disease Control and Prevention went remote during the pandemic. Most of the agency’s staff members haven’t returned to the office full time, raising concerns about the CDC’s ability to reform itself after recent stumbles.
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Private equity-backed Headlands Research heralded its covid-19 vaccine trials as a chance to boost participation among diverse populations, then it shuttered multiple sites that conducted them.
The United States is suffering from a severe shortage of affordable housing. But elected officials have done little to fix a problem that puts many Americans at greater risk for sickness and shortens lives.
Improving lung cancer outcomes in Black communities will take more than lowering the screening age, experts say. Disparities are present in everything from the studies that inform when people should get checked to the availability of care in rural areas.
Some doctors and medical practices voluntarily give rebates on a bill if an injury occurs during a procedure, while others will not, an expert says. Here’s how patients can respond.
Federally funded clinics and their doctors are protected against lawsuits by federal law, with taxpayers footing the bill. The health centers say that allows them to better serve their low-income patients, but lawyers say the system handcuffs consumers with a cumbersome legal process and makes it harder for the public to see problems.
Privacy concerns and coverage limits have long made insurance an unreliable option for abortion access. For decades, abortion funds have been stepping in to help people pay for what they see as essential health care.
With a dearth of evidence on effective treatments for long covid, patients and doctors in 400 clinics around the country still rely on trial and error.
The cash represents an unprecedented opportunity to derail the opioid epidemic, but with countless groups advocating for their share of the pie, the impact could depend heavily on geography and politics.
For decades, many women of color, particularly those with low incomes, had little control over their family planning care. Now, a White House effort aims to give patients more choices as abortion care evaporates, but patients remain wary of providers.
The popularity of at-home covid tests has amplified calls from public health researchers and diagnostic companies to make home testing similarly routine for sexually transmitted diseases. But FDA guidelines are lagging.
Federal officials have apparently stopped fighting Georgia’s plan for a limited Medicaid expansion that includes work requirements. The plan, a key policy of Republican Gov. Brian Kemp’s, would cover a much smaller portion of the population: those who can work or volunteer 80 hours a month.
Hospitals strike deals with financing companies, generating profits for lenders, and more debt for patients.
Low-income residents in states that haven’t expanded Medicaid are in a tough spot: They don’t qualify for the subsidies that people with slightly higher incomes get to buy marketplace plans because of a glitch in the federal health law. But a court decision last year makes it easier for them to make good-faith estimates of a pay increase, and there is no financial penalty if they don’t hit that figure.
As the covid-19 pandemic raged, an independent nonprofit tied to the Centers for Disease Control and Prevention hired an army of seasoned professionals to fill the gaps in the country’s public health system. Now, the money has largely run out, and state and local health departments are again without their expertise.
Private equity firms have shelled out almost $1 trillion to acquire nearly 8,000 health care businesses, in deals almost always hidden from federal regulators. The result: higher prices, lawsuits, and complaints about care.
Many Americans with intellectual and developmental disabilities do not have long-term plans for when family members can no longer care for them. Families, researchers, and advocates worry that has set the stage for a crisis in which people with disabilities could end up living in institutional settings.
© 2026 KFF